Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
- PMID: 36266326
- DOI: 10.1038/s41375-022-01724-9
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes
Similar articles
-
Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).Haematologica. 2011 Jan;96(1):55-61. doi: 10.3324/haematol.2010.026252. Epub 2010 Oct 22. Haematologica. 2011. PMID: 20971817 Free PMC article.
-
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.Am J Hematol. 2023 Mar;98(3):481-492. doi: 10.1002/ajh.26812. Epub 2023 Jan 5. Am J Hematol. 2023. PMID: 36606297 Review.
-
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.Leuk Lymphoma. 2015;56(11):3222-6. doi: 10.3109/10428194.2015.1026900. Epub 2015 May 12. Leuk Lymphoma. 2015. PMID: 25813079 Review. No abstract available.
-
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.Virchows Arch. 2022 Oct;481(4):621-646. doi: 10.1007/s00428-022-03375-8. Epub 2022 Jul 11. Virchows Arch. 2022. PMID: 35819517 Free PMC article.
-
Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.Pathobiology. 2007;74(2):97-114. doi: 10.1159/000101709. Pathobiology. 2007. PMID: 17587881 Review.
Cited by
-
Frontline treatment options for higher-risk MDS: can we move past azacitidine?Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):65-72. doi: 10.1182/hematology.2023000421. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066872
-
Are We Ready For "Triplet" Therapy in Higher-Risk MDS?Clin Hematol Int. 2023 Nov 3;5(4):88301. doi: 10.46989/001c.88301. eCollection 2023. Clin Hematol Int. 2023. PMID: 37933301 Free PMC article.
-
Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC.Leukemia. 2023 Oct;37(10):2138-2141. doi: 10.1038/s41375-023-02004-w. Epub 2023 Aug 12. Leukemia. 2023. PMID: 37573403 Free PMC article. No abstract available.
-
AML classification in the year 2023: How to avoid a Babylonian confusion of languages.Leukemia. 2023 Jul;37(7):1413-1420. doi: 10.1038/s41375-023-01909-w. Epub 2023 Apr 29. Leukemia. 2023. PMID: 37120689 Free PMC article.
References
-
- Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data. Blood. 2022:140;1200–28.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical